Neurofunctional mechanisms of unipolar depressive disorders - The role of limbic-cortical networks in diagnostic and therapy;Neurofunktionelle grundlagen unipolarer depressiver störungen - Die rolle limbisch-kortikaler netzwerke in der diagnostik und therapie

Nervenheilkunde

Volumn 24, Issue 7, 2005, Pages 603-610

  Vasic, Nenad ^a   Wolf, R C ^a   Walter, H ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Functional imaging; Limbic cortical networks; Therapy improvement; Unipolar depression

Indexed keywords

BRAIN CORTEX; BRAIN FUNCTION; DISEASE MODEL; LIMBIC CORTEX; MAJOR DEPRESSION; NEUROIMAGING; REVIEW;

EID: 25844494327     PISSN: 07221541     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1629995     Document Type: Review

References (82)

1. Alexander GE. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annual Reviews in Neuroscience 1986; 9: 357-81.
2. Alexander GE, Crutcher MD, DeLong MR. Basal ganglia-thalamocortical circuits: Parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions. Progress in Brain Research 1990; 85:119-46.
3. Altshuler LL et al. Amygdala enlargement in bipolar disorder and hippocampal reduction in schizophrenia: an MRI study demonstrating neuroanatomic specificity. Arch Gen Psychiatry 1998; 55: 663-4.
4. Bagby RM, Joffe RT, Parker JDA. Major depression and the five-factor model of personality. J Personal Disord 1995; 9: 224-34.
5. Bench CJ et al. The anatomy of melancholia - focal abnormalities of cerebral blood flow in major depression. Psychol Med. 1992; 22: 607-15.
6. Bench CJ et al. Investigations of the functional anatomy of attention using the Stroop test. Neuropsychologia 1993; 31: 907-22.
7. Berman KF et al. Is the mechanism of prefrontal hypofunction in depression the same as in schizophrenia? Regional cerebral blood flow during cognitive activation. Br J Psychiatry 1993; 162: 183-92.
8. Bhagwagar Z et al. Persistent reduction in brain serotonin1A receptor binding in recovered depressed men measured by positron emission tomography with [11C]WAY-100635. Mol Psychiatry. 2004; 9: 386-92.
9. Bowley MP et al. Low glial numbers in the amygdala in major depressive disorder. Biol Psychiatry 2002; 52: 404-12.
10. Brannan SK, Mayberg HS, McGinnis. Cingulate metabolism predicts treatment response: a replication. Biol Psychiatry 2000; 47: 107S.
11. Bremner JD et al. Hippocampal volume reduction in major depression. Am J Psychiatry 2000; 157: 115-8.
12. Bush G, Luu P, Posner MI. Cognitive and emotional influences in anterior cingulate cortex. Trends Cogn Sci 2000; 4: 215-22.
13. Carmichael ST, Price JL. Limbic connections of the orbital and medial prefrontal cortex in macaque monkeys. J Comp Neurol. 1995; 25: 615-41.
14. Coffey CE et al. Quantitative cerebral anatomy of the aging human brain: a cross-sectional study using magnetic resonance imaging. Neurology 1992; 42: 527-36.
15. Coffey CE et al. Quantitative cerebral anatomy in depression. A controlled magnetic resonance imaging study. Arch Gen Psychiatry. 1993a; 50: 7-16.
16. Coffey CE et al. The dexamethasone suppression test and quantitative cerebral anatomy in depression. Biol Psychiatry. 1993b; 33: 442-9.
17. Davidson RJ et al. The neural substrates of affective processing in depressed patients treated with venlafaxine. Am J Psychiatry 2003; 160: 64-75.
18. Davidson RJ, Putnam KM, Larson CL. Dysfunction in the neural circuitry of emotion regulation- a possible prelude to violence. Science 2000; 28: 591-4.
19. Dolan RJ et al. Neuropsychological dysfunction in depression: the relationship to regional cerebral blood flow. Psychol Med. 1994; 24: 849-57.
20. Doherty J et al. Abstract reward and punishment representations in the human orbitofrontal cortex. Nat Neurosci. 2001; 4: 95-102.
21. Dougherty DD et al. Cerebral metabolic correlates as potential predictors of response to anterior cingulotomy for treatment of major depression. J Neurosurg. 2003; 99: 1010-7.
22. Drevets WC. Functional anatomical abnormalities in limbic and prefrontal cortical structures in major depression. Prog Brain Res. 2000; 126: 413-31.
23. Drevets WC, Bogers W, Raichle ME. Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism. Eur Neuropsychopharmacol. 2002; 12: 527-44.
24. Drevets WC et al. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 1997; 24: 824-7.
25. Drevets WC, Raichle ME. Neuroanatomical circuits in depression: implications for treatment mechanisms. Psychopharmac Bull 1992; 28: 261-74.
26. Drevets WC et al. A functional anatomical study of unipolar depression. J Neurosci. 1992; 12: 3628-41.
27. Ebert D, Ebmeier KP. The role of the cingulate gyrus in depression: from functional anatomy to neurochemistry. Biol Psychiatry 1996; 15: 1044-50.
28. Elliott R. The neuropsychological profile in unipolar depression. Trends in Cognitive Sciences 1998; 2: 447-54.
29. Elliott R et al. Prefrontal dysfunction in depressed patients performing a complex planning task: a study using positron emission tomography. Psychol Med. 1997; 27: 931-42.
30. Erk S, Walter H, Spitzer M. Functional Neuroimaging of Depression. Perspectives in Affective Disorders. Adv Biol Psychiatry 2000; 21; 63-69.
31. Frodl T et al. Enlargement of the amygdala in patients with a first episode of major depression. Biol Psychiatry 2002; 51: 708-14.
32. Fu CHY, Walsh ND, Drevets WC. Neuroimaging : studies of mood disorders. In: Fu CHY, Senior C, Russell TA, Weinberger D, Murray R (eds). Neuroimaging in psychiatry. Washington: MD, Taylor & Francis 2003; 131-69.
33. Galynker II et al. Hypofrontality and negative: symptoms in major depressive disorder. J Nucl Med. 1998; 39: 608-12.
34. George MS et al. Blunted left cingulate activation in mood disorder subjects during a response interference task (the Stroop). J Neuropsychiatry Clin Neurosci. 1997; 9: 55-63.
35. George MS, Ketter TA, Post RM. SPECT and PET imaging in mood disorders. J Clin Psychiatry 1993; 54 Suppl: 6-13.
36. Goldapple K et al. Modulation of cortical-limbic pathways in major depression: treatment-specific effects of cognitive behavior therapy. Arch Gen Psychiatry. 4; 61: 34-41.
37. Holthoff VA et al. Changes in brain metabolism associated with remission in unipolar major depression. Acta Psychiatr Scand. 2004; 110: 184-94.
38. Husain MM et al. A magnetic resonance imaging study of putamen nuclei in major depression. Psychiatry Res. 1991; 40: 95-9.
39. Kendler KS et al. The prediction of major depression in women: toward an integrated etiologic model. Am J Psychiatry. 1993; 150: 1139-48.
40. Kennedy SH et al. Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression. Am J Psychiatry 2001; 158: 899-905.
41. Krishnan KR et al. Magnetic resonance imaging of the caudate nuclei in depression. Preliminary observations. Arch Gen Psychiatry 1992; 49: 553-7.
42. Kumar A et al. Quantitative anatomic measures and comorbid medical illness in late-life major depression. Am J Geriatr Psychiatry. 1997; 5: 15-25.
43. Liotti M, Mayberg HS. The role of functional neuroimaging in the neuropsychology of depression. J Clin Exp Neuropsychol. 2001; 23: 121-36.
44. Liotti M et al. An ERP study of mood provocation in remitted depression. Abstracts of the Society for Neuroscience 1996; 23: 1657.
45. Lu L et al. Modification of hippocampal neurogenesis and neuroplasticity by social environments. Exp Neurol. 2003; 183: 600-9.
46. MacQueen GM et al. Course of illness, hippocampal function, and hippocampal volume in major depression. Proc Natl Acad Sci USA 2003; 4: 1387-92.
47. Malberg JE, Duman RS. Cell proliferation in adult hippocampus is decreased by inescapable stress: reversal by fluoxetine treatment. Neuropsychopharmacology 2003; 28: 1562-71.
48. Mayberg HS. Modulating limbic-cortical circuits in depression: targets of antidepressant treatments. Semin Clin Neuropsychiatry. 2002; 7: 255-68.
49. Mayberg HS. Positron emission tomography imaging in depression: a neural systems perspective. Neuroimaging Clin N Am. 2003; 13: 805-15.
50. Mayberg HS et al. Cingulate function in depression: a potential predictor of treatment response. Neuroreport 1997; 3 1057-61.
51. Mayberg HS et al. Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. Am J Psychiatry 1999; 156: 675-82.
52. Meaney MJ et al. Molecular basis for the development of individual differences in the hypothalamic-pituitary-adrenal stress response. Cell Mol Neurobiol. 1993; 13: 321-47.
53. Mega MS, Cummings JL. Frontal-subcortical circuits and neuropsychiatrie disorders. J Neuropsychiatry Clin Neurosci. 1994; 6: 358-70.
54. Mega MS et al. The limbic system: an anatomic, phylogenetic, and clinical perspective. J Neuropsychiatry Clin Neurosci. 1997; 9: 315-30.
55. Messa C et al. 5-HT(2A) receptor binding is reduced in drug-naive and unchanged in SSRI-responder depressed patients compared to healthy controls: a PET study. Psychopharmacology (Berl). 2003; 167: 72-8.
56. Meyer JH et al. Lower dopamine transporter binding potential in striatum during depression. Neuroreport. 2001; 12: 4121-5.
57. Michaud CM, Murray CJ, Bloom BR. Burden of disease - implications for future research JAMA 2001; 285: 535-9.
58. Nauta WJ. Neural associations of the frontal cortex. Acta Neurobiol Exp 1972; 32: 125-40.
59. Navarro V et al. Frontal cerebral perfusion after antidepressant drug treatment versus ECT in elderly patients with major depression: a 12-month follow-up control study. J Clin Psychiatry 1972; 65: 656-61.
60. Navarro V et al. Prognostic value of frontal functional neuroimaging in late-onset severe major depression. Br J Psychiatry 2004; 184: 306-11.
61. Neumeister A et al. Reduced serotonin type 1A receptor binding in panic disorder. J Neurosci. 2004; 21: 589-91.
62. Overstreet DH. The Flinders sensitive line rats: a genetic animal model of depression. Neurosci Biobehav Rev. 1993; 17: 51-68.
63. Paquette V et al. "Change the mind and you change the brain": effects of cognitive-behavioral therapy on the neural correlates of spider phobia. Neuroimage 2003; 18: 401-9.
64. Rajkowska G. Depression: what we can learn from postmortem studies. Neuroscientist 2003; 9: 273-84.
65. Rajkowska G et al. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol Psychiatry 1999; 1: 1085-98.
66. Santarelli L et al. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 2003; 8: 805-9.
67. Seminowicz DA et al. Limbic-frontal circuitry in major depression: a path modeling metanalysis. Neuroimage 2004; 22: 409-18.
68. Shah PJ et al. Cortical grey matter reductions associated with treatment-resistant chronic unipolar depression. Controlled magnetic resonance imaging study. Br J Psychiatry 1998; 172: 527-32.
69. Sheline YI. Neuroimaging studies of mood disorder effects on the brain. Biol Psychiatry 2003; 54: 338-52.
70. Sheline YI, Gado MH, Price JL. Amygdala core nuclei volumes are decreased in recurrent major depression. Neuroreport 1998; 22: 2023-8.
71. Simpson HB et al. Serotonin transporters in obsessive-compulsive disorder: a positron emission tomography study with [(11)C]McN 5652. Biol Psychiatry. 2003; 15: 1414-21.
72. Soares JC, Mann JJ. The functional neuroanatomy of mood disorders. J Psychiatr Res 1997; 31: 393-432.
73. Stefurak T, Mahurin R, Soloman D. Response specific regional metabolism changes with fluoxetine treatment in depressed Parkinson's patients. Movement Disorders 2001; 16 (Suppl. 1): S39.
74. Strakowski SM, Adler CM, DelBello MP. Volumetric MRI studies of mood disorders: do they distinguish unipolar and bipolar disorder? Bipolar Disord 2002; 4: 80-8.
75. Strakowski SM. Brain magnetic resonance imaging of structural abnormalities in bipolar disorder. Arch Gen Psychiatry 1999; 56(3): 254-60.
76. Swerdlow NR, Koob GF. Dopamine, schizophrenia, mania and depression: toward a unified hypothesis of cortico-striato-pallido-thalamic function. Behav Brain Sci 1987; 10: 197-245.
77. Tebartz van Elst L. Bildgebende Befunde bei affektiven Störungen. In: Walter H. (Hrsg.). Funktionelle Bildgebung in Psychiatrie und Psychotherapie. Stuttgart, New York: Schattauer Verlag 2004; 274-302.
78. Vogel G. Neuroscience. Depression drugs' powers may rest on new neurons. Science 2003; 8: 757.
79. Vogt BA, Pandya DN. Cingulate cortex of the rhesus monkey: II. Cortical afferents. J Comp Neurol. 1987; 8: 271-89.
80. Walter H. Neurowissenschaft der Emotionen und Psychiatrie. Nervenheilkunde 1999; 18: 116-126.
81. Walter H. (Hrsg.). Funktionelle Bildgebung in Psychiatrie und Psychotherapie. Stuttgart, New York: Schattauer Verlag 2004.
82. Yatham LN et al. Brain serotonin2 receptors in major depression: a positron emission tomography study. Arch Gen Psychiatry 2000; 57: 850-8.